EDGAR Filing Documents for 0001393905-22-000358

Form 1-A - Offering Statement [Regulation A]:

SEC Accession No. 0001393905-22-000358

Filing Date

2022-09-13

Accepted

2022-09-13 16:28:36

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	1-A
1		primary_doc.xml	1-A	9298
2	PART II	lphm_1a.htm	PART II AND III	656587
3	ARTICLES OF INCORPORATION	lphm_ex21.htm	EX1A-2A CHARTER	104168
4	BYLAWS	lphm_ex22.htm	EX1A-2B BYLAWS	56739
5	AMENDMENT TO ARTICLES OF INCORPORATION	lphm_ex23.htm	EX1A-2A CHARTER	14092
6	SUBSCRIPTION AGREEMENT	lphm_ex41.htm	EX1A-4 SUBS AGMT	39167
7	AUDITORS CONSENT	lphm_ex111.htm	EX1A-11 CONSENT	3539
8	LEGAL OPINION AND CONSENT	lphm_ex121.htm	EX1A-12 OPN CNSL	7556
9		lphm1a_1.jpg	GRAPHIC	3196
10		lphmex21_1.jpg	GRAPHIC	1095
11		lphmex111_1.jpg	GRAPHIC	5496
12		lphmex121_1.jpg	GRAPHIC	4864
13		lphmex23_1.jpg	GRAPHIC	1095
14		lphmex21_3.jpg	GRAPHIC	17011
15		lphmex21_7.jpg	GRAPHIC	29125
16		lphmex21_5.jpg	GRAPHIC	36151
17		lphmex21_2.jpg	GRAPHIC	60851
18		lphmex21_6.jpg	GRAPHIC	105326
19		lphmex21_4.jpg	GRAPHIC	98051
	Complete submission text file	0001393905-22-000358.txt		1392658

Mailing Address 30 N GOULD STREET SUITE 5835 SHERIDAN WY 82801

Business Address 30 N GOULD STREET SUITE 5835 SHERIDAN WY 82801 307-278-1360

Lee Pharmaceuticals, Inc. (Filer) CIK: 0000058411 (see all company filings)